Unravelling the Role of Sphingosine-1-Phosphate Signaling in Promoting Aortic Stenosis

Aortic Stenosis (AS) is one of the most common life-threatening cardiovascular conditions, particularly among the aging population. AS is characterized by the progressive narrowing of the aortic valve due to calcific degeneration, leading to increased left ventricular workload, heart failure, and ultimately, mortality if left untreated.1,2 Historically, AS has been considered a passive degenerative disease associated with aging and mechanical stress. However, recent research has shed light on the active molecular and cellular mechanisms that drive its progression.1,3 One such emerging pathway of interest is Sphingosine-1-Phosphate (S1P) signalling, which has been identified as a crucial modulator of osteogenic differentiation and valvular calcification. The recent study offers critical insights into the mechanistic role of S1P signalling in AS and proposes a potential therapeutic avenue for intervention.